Rossari Biotech Limited announced that at the board meeting held on April 29, 2023, the company approved Ms. Manasi will cease to be CFO and KMP of the Company with effect from close of business hours on April 30, 2023. Mr. Ketan Sablok being a Group - Chief Financial Officer and Key Managerial Personnel of the Company will act as the Chief Financial Officer of the Company in terms of provisions of Section 203 of the Companies Act, 2013 with effect from May 01, 2023. Mr. Ketan Sablok, has been
associated with the Company as
Group - Chief Financial Officer from
November, 2021. Mr. Ketan Sablok, has over 25 years of rich experience in Strategic Finance functions, Taxation, Treasury, Investor Relations and Accounts. Mr. Sablok has contributed enormously in the process of acquisitions, capital expansion projects, disinvestments, forging partnership and implementing a robust budgeting system. He is a fellow member of the Institute of Chartered Accountants of India and the Institute of Cost & Management Accountants of India. He also holds a Bachelor's degree in Commerce (Honours) from St. Xaviers' College, Kolkata.